section name header

Basics

Bettina Knoll (E. Mylonakis, Editor)


BASICS


DESCRIPTION navigator

EPIDEMIOLOGY

Incidence navigator

Anaerobes account for up to 10% of blood culture isolates from patients with clinically significant bacteremia (1). No incidence data is available for anaerobic infections of other sites.

RISK FACTORS navigator

GENERAL PREVENTION navigator

PATHOPHYSIOLOGY navigator

ETIOLOGY navigator

COMMONLY ASSOCIATED CONDITIONS navigator


[Outline]

Diagnosis

DIAGNOSIS


HISTORY navigator

PHYSICAL EXAM navigator

DIAGNOSTIC TESTS & INTERPRETATION

Lab navigator

Imaging navigator

Diagnostic Procedures/Other navigator

CT- or US-guided aspiration or biopsy

DIFFERENTIAL DIAGNOSIS navigator

Anaerobic lung abscesses have to be differentiated from mycobacterial diseases.


[Outline]

Treatment

TREATMENT


Ongoing Care

ONGOING-CARE


FOLLOW-UP RECOMMENDATIONS

Patient Monitoring navigator

COMPLICATIONS navigator

Contiguous spread of untreated infections


[Outline]

Codes

CODES


ICD9

041.84 Other specified bacterial infections in conditions classified elsewhere and of unspecified site, other anaerobes

References

  1. Lassmann B, Gustafson DR, Wood CM, et al. Reemergence of anaerobic bacteremia. Clin Infect Dis 2007;44(7):895–900.
  2. Snydman DR, Jacobus NV, McDermott LA, et al. National survey on the susceptibility of Bacteroides fragilis group: Report and analysis of trends in the United States from 1997 to 2004. Antimicrob Agents Chemother 2007;51(5):1649–1655.